Medicare Enrolled
Dr. Omid Vahdat, M.D.
Interventional Cardiology · Los Alamitos, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Vahdat from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vahdat?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vahdat
Dr. Omid Vahdat is an interventional cardiology specialist in Los Alamitos, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Vahdat performed 8,689 Medicare services across 5,158 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vahdat received a total of $32,025 from 49 pharmaceutical and/or device companies across 640 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vahdat is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 11% volume in CA
$32,025 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,689
Medicare services
Top 11% in CA for interventional cardiology
5,158
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~457 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,363 | $67 | $157 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,161 | $101 | $227 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
996 | $102 | $279 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
917 | $11 | $100 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
894 | $67 | $198 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
557 | $168 | $645 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
514 | $146 | $442 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
375 | $9 | $27 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
259 | $7 | $20 |
| Stress echocardiogram An ultrasound of the heart performed while at rest and during exercise or drug-induced stress to evaluate heart function under different conditions. |
224 | $159 | $569 |
| New patient office visit, complex (60-74 min) | 172 | $173 | $480 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
144 | $21 | $72 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
116 | $19 | $72 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
113 | $25 | $74 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
105 | $63 | $153 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
84 | $29 | $60 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
82 | $10 | $122 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
79 | $179 | $609 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
55 | $140 | $396 |
| Cardiac catheterization | 53 | $200 | $682 |
| Ultrasound guided compression repair of blood vessel | 44 | $78 | $222 |
| Evaluation of implantable heart and blood vessel monitoring system This procedure involves checking the function and data of an implanted device used to monitor heart and blood vessel activity. |
44 | $45 | $90 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
40 | $12 | $42 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
38 | $18 | $54 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
37 | $112 | $386 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
35 | $65 | $173 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
35 | $31 | $147 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
33 | $12 | $34 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
32 | $77 | $220 |
| Programming of dual lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with two leads to ensure proper function. |
30 | $83 | $184 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
22 | $170 | $462 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
13 | $476 | $1,327 |
| Stent placement and plaque removal in one vessel A procedure to clear plaque and blood clots from a single blood vessel, followed by the insertion of a stent and/or balloon dilation to keep the vessel open. |
12 | $534 | $1,487 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
11 | $96 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.2% high complexity
5.8% medium
82.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$32,025
Total received (2018-2024)
Avg $4,575/year across 7 years
Top 18% in CA for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
640
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,182 (56.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$7,171 (22.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,671 (20.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,208
2023
$5,045
2022
$2,388
2021
$2,306
2020
$3,383
2019
$1,466
2018
$15,228
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Edwards Lifesciences Corporation
$367
AstraZeneca Pharmaceuticals LP
$260
ABIOMED
$215
Janssen Pharmaceuticals, Inc
$197
Novartis Pharmaceuticals Corporation
$180
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$129
Kiniksa Pharmaceuticals International, plc
$121
SCPHARMACEUTICALS INC.
$91
Abbott Laboratories
$77
Merck Sharp & Dohme LLC
$76
Amgen Inc.
$76
Lilly USA, LLC
$75
E.R. Squibb & Sons, L.L.C.
$58
Alnylam Pharmaceuticals Inc.
$46
CVRx, Inc.
$38
PFIZER INC.
$30
Actelion Pharmaceuticals US, Inc.
$29
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Bayer Healthcare Pharmaceuticals Inc.
$29
Lexicon Pharmaceuticals, Inc.
$28
Boston Scientific Corporation
$27
Celgene Corporation
$16
Esperion Therapeutics, Inc.
$15
Top 3 companies account for 38.1% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$9,672
Amgen Inc.
$7,599
ABIOMED
$2,610
Janssen Pharmaceuticals, Inc
$1,209
Novartis Pharmaceuticals Corporation
$1,186
PFIZER INC.
$990
Edwards Lifesciences Corporation
$943
AstraZeneca Pharmaceuticals LP
$863
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$709
E.R. Squibb & Sons, L.L.C.
$679
Boehringer Ingelheim Pharmaceuticals, Inc.
$664
Merck Sharp & Dohme LLC
$452
Amarin Pharma Inc.
$437
Lilly USA, LLC
$412
Medtronic Vascular, Inc.
$357
Bayer HealthCare Pharmaceuticals Inc.
$308
Esperion Therapeutics, Inc.
$298
Kowa Pharmaceuticals America, Inc.
$245
SANOFI-AVENTIS U.S. LLC
$221
Regeneron Healthcare Solutions, Inc.
$166
Impulse Dynamics (USA) Inc.
$163
Alnylam Pharmaceuticals Inc.
$140
Otsuka America Pharmaceutical, Inc.
$133
Philips Electronics North America Corporation
$132
Merck Sharp & Dohme Corporation
$125
BIOTRONIK INC.
$124
SCPHARMACEUTICALS INC.
$121
Kiniksa Pharmaceuticals International, plc
$121
Bayer Healthcare Pharmaceuticals Inc.
$120
Boston Scientific Corporation
$113
CVRx, Inc.
$80
PORTOLA PHARMACEUTICALS, INC.
$76
Kestra Medical Technology Services, Inc.
$74
Lantheus Medical Imaging, Inc.
$68
ARBOR PHARMACEUTICALS, INC.
$66
GlaxoSmithKline, LLC.
$58
Bardy Diagnostics, Inc.
$42
Actelion Pharmaceuticals US, Inc.
$29
Lexicon Pharmaceuticals, Inc.
$28
La Jolla Pharmaceutical Company
$25
Shire North American Group Inc
$23
Novo Nordisk Inc
$23
Astellas Pharma US Inc
$21
IDORSIA PHARMACEUTICALS US INC
$21
AngioDynamics, Inc.
$18
GE HEALTHCARE
$17
Celgene Corporation
$16
Medicure Pharma Inc.
$15
ShockWave Medical, Inc
$14
Top 3 companies account for 62.1% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · AMVUTTRA · ANDEXXA · AVEIR · Amplia MRI · Arcalyst · Assure WCD · Assurity Pacemaker · BEVYXXA · BIOMONITOR · BOOSTRIX · BRILINTA · Barostim Neo System · CAMZYOS · CARDIOMEMS · CHANTIX · Carnation Ambulatory Monitor · Confirm Rx · Corlanor · DEFINITY · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · EVENITY · Edarbi · Edora 8 DR-T · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FUROSCIX · GENERAL PAIN MANAGEMENT · GIAPREZA · GLASSIA · General - Therapies · IGT D Coronary · INNOVA · INVOKANA · Impella · JANUVIA · JARDIANCE · JYNARQUE · Kerendia · LEQVIO · LEXISCAN · LOKELMA · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MOUNJARO · MULTAQ · Micra · MitraClip System · NEXLETOL · ONPATTRO · OPSUMIT · OPTIMIZER · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pacemakers · QUVIVIQ · Repatha · Resolute · Respiratoriy Care Undiv · Reveal LINQ · Rivacor · Rybelsus · SAMSCA · SEGLENTIS · SHINGRIX · TENDRIL · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TRADJENTA · TRAcelet · TRULICITY · VAXNEUVANCE · VERQUVO · VYNDAQEL · Vascepa · Vascular Lithotripsy · VenaCure 1470 Pro · WAINUA · XARELTO · ZYPITAMAG (pitavastatin)
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (57%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional cardiologists within 10 mi
85
Per 100K population
2.7
County median income
$113,702
Nearest hospital
UCI HEALTH - LOS ALAMITOS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Vahdat is a clinical cardiology specialist, with above-average Medicare volume (top 11% in CA), with low-engagement industry engagement in the top 18% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Vahdat experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Vahdat performed 1,363 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vahdat receive payments from pharmaceutical companies?
Yes. Dr. Vahdat received a total of $32,025 from 49 companies across 640 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vahdat's costs compare to other interventional cardiologists in Los Alamitos?
Dr. Vahdat's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vahdat) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Los Alamitos
Browse interventional cardiologists in Los Alamitos ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in CA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in CA
Which CA interventional cardiologists receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology